生晶藥廠BCRX
那斯達克 · USD
9.96
-0.13
(-1.29%)
收盤 09/05 03:59 (UTC+8)
09/05 03:59 (UTC+8)
生晶藥廠BCRX
9.96
-0.13
(-1.29%)
財務數據
損益表
- 0.93
- 1.09
- 1.17
- 1.32
- 1.46
- 1.63
- 1.59
- 4.07
- 1.56
- 2.18
- -0.69
- 17.86
- 7.09
- 12.34
- 10.64
- 12.24
- -2.42
- 155.06
- -61.53
- 39.53
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 218,250 | 156,413 | 406,555 | 159,395 | 163,353 | 145,534 | 131,534 | 117,085 | 109,332 | 92,761 |
營業成本 | 3,840 | 5,377 | 9,522 | 2,187 | 2,798 | 4,568 | 6,094 | 3,211 | 1,699 | 1,265 |
營業毛利 | 214,410 | 151,036 | 397,033 | 157,208 | 160,555 | 140,966 | 125,440 | 113,874 | 107,633 | 91,496 |
營業費用 | 115,945 | 852,634 | 136,648 | 127,617 | 130,769 | - | 129,948 | 106,182 | - | - |
研發費用 | 51,969 | 60,319 | 40,867 | 44,603 | 43,386 | 37,270 | 49,441 | 41,081 | 37,623 | 46,493 |
推銷及管理費用 | 63,976 | 94,554 | 95,781 | 83,014 | 87,383 | 82,469 | 80,291 | 65,084 | 61,087 | 59,364 |
非經常性項目費用 | - | 697,761 | - | - | - | - | 216 | 17 | 162 | 127 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 98,465 | -701,598 | 260,385 | 29,591 | 29,786 | 21,227 | -4,508 | 7,692 | 8,761 | -14,488 |
其他收入及費用 | 2,721 | 569 | 1,767 | 2,200 | -1,718 | 3,025 | 2,966 | 3,689 | 3,470 | 3,980 |
利息費用 | 21,712 | 19,779 | 14,135 | 19,661 | 21,582 | 23,494 | 24,449 | 24,828 | 24,733 | 24,506 |
稅前純益 | 79,474 | -720,808 | 248,017 | 12,130 | 6,486 | 758 | -25,991 | -13,447 | -12,502 | -35,014 |
所得稅 | 1,079 | 1,004 | 2,172 | -769 | 1,401 | 726 | 804 | 586 | 172 | 365 |
稅後純益 | 78,395 | -721,812 | 245,845 | 12,899 | 5,085 | 32 | -26,795 | -14,033 | -12,674 | -35,379 |
基本每股稅後盈餘(元) | 0.31 | -2.98 | 1.17 | 0.06 | 0.02 | - | -0.13 | -0.07 | -0.06 | -0.17 |
稀釋每股稅後盈餘(元) | 0.39 | -2.98 | 1.13 | 0.06 | 0.02 | - | -0.13 | -0.07 | -0.06 | -0.17 |
基本平均股數(千股) | 254481.00 | 242258.00 | 210969.00 | 210176.00 | 209519.00 | 208882.00 | 207381.00 | 206905.00 | 206425.00 | 206064.00 |
稀釋平均股數(千股) | 265165.00 | 242258.00 | 219263.00 | 219885.00 | 219886.00 | 215261.00 | 207381.00 | 206905.00 | 206425.00 | 206064.00 |
還原基本每股稅後盈餘(元) | 0.31 | -2.98 | 1.17 | 0.06 | 0.02 | - | -0.13 | -0.07 | -0.06 | -0.17 |
還原稀釋每股稅後盈餘(元) | 0.39 | -2.98 | 1.13 | 0.06 | 0.02 | - | -0.13 | -0.07 | -0.06 | -0.17 |
還原基本平均股數(千股) | 254,481 | 242,258 | 210,969 | 210,176 | 209,519 | 208,882 | 207,381 | 206,905 | 206,425 | 206,064 |
還原稀釋平均股數(千股) | 265,165 | 242,258 | 219,263 | 219,885 | 219,886 | 215,261 | 207,381 | 206,905 | 206,425 | 206,064 |
EBITDA(千元) | 101,485 | -699,568 | 261,455 | 30,416 | 26,703 | 23,200 | -3,993 | 9,653 | 9,058 | -13,383 |